Valuation : Clover Corporation Limited

Market Cap 152M 109M 93.7M 87.98M 80.31M 151M 10.35B 1.04B 406M 5.25B 409M 400M 17.39B P/E 2026 *
15.6x
P/E 2027 * 11.4x
Enterprise Value 150M 107M 92.28M 86.65M 79.1M 149M 10.2B 1.03B 399M 5.17B 402M 394M 17.12B EV / Sales 2026 *
1.59x
EV / Sales 2027 * 1.25x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day-4.92%
1 week-4.40%
Current month-9.38%
1 month-9.38%
3 months-13.00%
6 months+12.99%
Current year+10.13%
1 week 0.87
Extreme 0.87
0.98
1 month 0.87
Extreme 0.87
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
6/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-4.92%-4.40%+56.76%-15.53% 109M
-0.44%-2.88%+8.51%+65.67% 12.33B
-0.45%-9.80%-17.20%+315.02% 9.15B
-0.41%+0.82%-20.07%-49.12% 2.44B
-3.07%-1.14%-19.05%-7.17% 1.49B
+0.35%+0.18%+23.04%+77.51% 1.37B
-11.58%-12.64%+12.37%-26.83% 1.15B
+0.75%-0.74%-73.76%-74.05% 1.25B
+0.85%+7.47%-41.17% - 1.13B
+4.76%+4.38%-60.05%-68.26% 1.01B
Average -1.42%-0.37%-13.06%+24.14% 3.14B
Weighted average by Cap. -0.69%+0.73%-8.83%+114.62%

Financials

2026 *2027 *
Net sales 94M 67.32M 57.96M 54.43M 49.68M 93.33M 6.41B 645M 251M 3.25B 253M 247M 10.75B 116M 83.15M 71.59M 67.22M 61.36M 115M 7.91B 797M 310M 4.01B 312M 305M 13.28B
Net income 9.8M 7.02M 6.04M 5.67M 5.18M 9.73M 668M 67.24M 26.16M 339M 26.35M 25.78M 1.12B 13.5M 9.67M 8.32M 7.82M 7.14M 13.4M 920M 92.62M 36.04M 466M 36.3M 35.51M 1.54B
Net Debt -2.3M -1.65M -1.42M -1.33M -1.22M -2.28M -157M -15.78M -6.14M -79.48M -6.18M -6.05M -263M -7.2M -5.16M -4.44M -4.17M -3.81M -7.15M -491M -49.4M -19.22M -249M -19.36M -18.94M -824M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
01/09/26 A$0.8700 -4.92% 26,873
31/08/26 A$0.9150 -6.15% 11,960
28/08/26 A$0.9750 +7.73% 18,009
27/08/26 A$0.9050 +1.69% 41,001
26/08/26 A$0.8900 -1.93% 56,202
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9150AUD
Average target price
1.280AUD
Spread / Average Target
+39.89%

Annual profits - Rate of surprise